Published in Women's Health Weekly, February 15th, 1995
Will every woman in the trial receive tamoxifen'
The 16,000 women who will participate in the BCPT will be randomized (selected by chance) to receive either tamoxifen or a placebo (an inactive pill that looks like tamoxifen). In a process known as 'double blinding,' neither the participant nor her physician will know which pill she is receiving. Setting up a trial in this way allows researchers to clearly see what the true benefits and side effects of tamoxifen may be without the influence of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.